Full Text View
Tabular View
Study Results
Related Studies
HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone
This study has been completed.
Study NCT00839319   Information provided by University of Washington

First Received on February 6, 2009.   Last Updated on October 24, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy Males
Interventions listed in this trial
Acyline
placebo hCG (no active ingredient)
hCG (human chorionic gonadotropin)
Testosterone gel
Additional drug interventions recognized in this trial
Chorionic Gonadotropin
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services